Status:

COMPLETED

Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer

Lead Sponsor:

SCRI Development Innovations, LLC

Collaborating Sponsors:

Aventis Pharmaceuticals

GlaxoSmithKline

Conditions:

Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

In this phase II trial we attempt to improve upon the efficacy of the trastuzumab/vinorelbine combination by adding weekly docetaxel. When administered on a weekly schedule, docetaxel is well tolerate...

Detailed Description

Upon determination of eligibility, all patients will be receive: Trastuzumab + Vinorelbine + Docetaxel

Eligibility Criteria

Inclusion

  • To be included in this study, you must meet the following criteria:
  • Metastatic breast cancer confirmed by biopsy
  • Overexpression of the Her-2 oncogene
  • Age \> 18 years
  • Measurable disease
  • Able to perform activities of daily living with minimal assistance
  • No previous chemotherapy for metastatic disease
  • One or more previous hormonal therapies for metastatic disease.
  • Adequate bone marrow, liver and kidney function
  • Patients with \< grade 1 peripheral neuropathy are eligible.
  • Must give written informed consent prior to entering this study.

Exclusion

  • You cannot participate in this study if any of the following apply to you:
  • Abnormal heart function
  • Previous treatment with trastuzumab
  • Brain metastases untreated
  • Pre-existing symptomatic peripheral neuropathy
  • Serious underlying medical conditions
  • Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.

Key Trial Info

Start Date :

April 1 2001

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00193089

Start Date

April 1 2001

End Date

September 1 2009

Last Update

December 10 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.